0523 GMT - Thailand's Praram 9 Hospital is likely to benefit from the country's growing medical tourism industry, DBS Group Research's Sasikarn Udomvej says in a note. She expects foreign patients to have contributed to 25% of 2Q revenue, compared with 15% a year earlier. The segment's contribution will likely continue to exceed 20% in the long term, she adds. Praram 9's earnings for 2Q is expected have increased 41% to 195 million baht, supported by robust revenue growth. The strong earnings momentum is likely to continue into 2H, supported by international patients from the Middle East and Bangladesh, she adds. DBS maintains its buy rating and target of THB30.00. Shares are last at THB24.70. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

July 15, 2025 01:23 ET (05:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.